see more

A worker drives a forklift truck to transport boxes of the Sputnik V COVID-19 vaccine, developed by the Gamaleya National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), at the cargo terminal at Sheremetyevo International Airport OAO in Moscow, Russia, on Thursday, Feb. 11, 2021. Montenegro and St. Vincent and the Grenadines approved Russian-developed vaccine for use, bringing total number of countries that have authorized it to 26, Russian Direct Investment Fund says in statement. Photographer: Andrey Rudakov/Bloomberg via Getty Images

A worker drives a forklift truck to transport boxes of the Sputnik V COVID-19 vaccine, developed by the Gamaleya National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), at the cargo terminal at Sheremetyevo International Airport OAO in Moscow, Russia, on Thursday, Feb. 11, 2021. Montenegro and St. Vincent and the Grenadines approved Russian-developed vaccine for use, bringing total number of countries that have authorized it to 26, Russian Direct Investment Fund says in statement. Photographer: Andrey Rudakov/Bloomberg via Getty Images